about
A high-throughput molecular data resource for cutaneous neurofibromas.Drug discovery and development for Huntington's disease - an orphan indication with high medical need.Neurofibromatosis as a gateway to better treatment for a variety of malignancies.Novel Hits in the Correction of ΔF508-Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) Protein: Synthesis, Pharmacological, and ADME Evaluation of Tetrahydropyrido[4,3-d]pyrimidines for the Potential Treatment of Cystic Fibrosis.Fused 3-Hydroxy-3-trifluoromethylpyrazoles Inhibit Mutant Huntingtin Toxicity.Recombinant Adeno Associated Viral (AAV) vector type 9 delivery of Ex1-Q138-mutant huntingtin in the rat striatum as a short-time model for in vivo studies in drug discovery.Rethinking the nonprofit foundation: an emerging niche in the rare disease ecosystem.Creating a data resource: what will it take to build a medical information commons?Novel alpha-7 nicotinic acetylcholine receptor agonists containing a urea moiety: identification and characterization of the potent, selective, and orally efficacious agonist 1-[6-(4-fluorophenyl)pyridin-3-yl]-3-(4-piperidin-1-ylbutyl) urea (SEN3462A prototype solid phase synthesis of pteridines and related heterocyclic compounds.Traditional and systems biology based drug discovery for the rare tumor syndrome neurofibromatosis type 2.Probing the chemical-biological relationship space with the Drug Target ExplorerEfficient Synthesis of 3,5-Dicarbamoyl-1,4-dihydropyridines from Pyridinium Salts: Key Molecules in Understanding NAD(P)+/NAD(P)H PathwaysCutaneous neurofibromas in the genomics era: current understanding and open questionsProbing the chemical-biological relationship space with the Drug Target ExplorerThe synthesis of 7-deazaguanines as potential inhibitors of guanosine triphosphate cyclohydrolase IA traceless solid-phase synthesis of pteridinesFunding community collaboration to develop effective therapies for neurofibromatosis type 1 tumorsEngaging a community to enable disease-centric data sharing with the NF Data PortalThe evolution and multi-molecular properties of NF1 cutaneous neurofibromas originating from C-fiber sensory endings and terminal Schwann cells at normal sites of sensory terminations in the skin
P50
Q36343064-F6F65F1E-EB5A-4369-9A26-CE24B9D56153Q37258409-122803CA-5688-4E3C-9EB7-BEAACB8113B6Q38725743-16F2DEB6-28A9-4275-BCFA-FB3ABF2ACBB6Q38820019-78D0A283-F0DE-4560-8FBD-7ECF0B8CD33FQ39772092-EFDAD827-3E53-43E6-9DC9-F0E2EC5EC9EDQ40887305-37FD3A82-C0BE-4DCC-A1B1-A62703E98172Q41600985-EB4661C9-7B28-46EE-BBBE-C4766C6B9FBDQ42127153-F2F426C7-9554-43CE-A7F3-DD965538D419Q43064829-99CA29BD-9A49-428C-9BED-C2C585688556Q44566762-26D092EC-D0CF-4E42-9988-1D8B387A45A9Q55383186-CB5FFFBE-BF31-4866-AAAB-881CF7CB9EE5Q58765551-7067446A-DD0F-4C83-97B4-D3C079FF560AQ58961031-8CC1FC0B-3DD0-48F3-859B-3FA535BE73E9Q60787182-56931239-4913-4902-8FCE-EFB814C1C7A8Q60787185-4618A221-CEB4-48BA-A9C6-CDFBCEA60041Q62551438-7D8410BA-C12A-4293-AEEE-40A8D1751DF9Q62551460-56A54077-0AAE-4E76-ACCE-A7A07B2C9D06Q91626953-709557C5-B45D-4B9E-9A17-081F6B6C2117Q91972884-8B82AB43-7896-46CF-9619-5C794A1374A2Q92157001-4C6B18F6-1DE0-431A-B6AC-20EE0396D3BB
P50
description
hulumtues
@sq
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Salvatore La Rosa
@ast
Salvatore La Rosa
@en
Salvatore La Rosa
@es
Salvatore La Rosa
@nl
Salvatore La Rosa
@sl
type
label
Salvatore La Rosa
@ast
Salvatore La Rosa
@en
Salvatore La Rosa
@es
Salvatore La Rosa
@nl
Salvatore La Rosa
@sl
altLabel
Salvo La Rosa
@en
prefLabel
Salvatore La Rosa
@ast
Salvatore La Rosa
@en
Salvatore La Rosa
@es
Salvatore La Rosa
@nl
Salvatore La Rosa
@sl
P106
P1153
55403021300
P21
P31
P496
0000-0003-2010-4328